Steven Isserman, MD
Cardiovascular Disease · Morganton, NCNPI 1518920271
Payments from drug & device makers
Across 380 payments — averaging $2070.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$453K
- Amgen$275K
- Merck$19K
- Kowa Research Institute, Inc.$18K
- AstraZeneca$13K
- Esperion Therapeutics, Inc.$4K
- plus $6K from 17 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 40 | $452,748 |
| Amgen | 27 | $274,864 |
| Merck | 31 | $19,098 |
| Kowa Research Institute, Inc. | 18 | $17,634 |
| AstraZeneca | 50 | $13,261 |
| Esperion Therapeutics, Inc. | 12 | $3,646 |
| Abbott | 62 | $2,248 |
| Pfizer | 40 | $715 |
| Medtronic | 8 | $680 |
| E.r. Squibb & Sons, L.L.C. | 40 | $608 |
| Boehringer Ingelheim | 20 | $504 |
| Johnson & Johnson | 8 | $174 |
| Amarin Pharma, Inc. | 3 | $154 |
| Novo Nordisk | 4 | $149 |
| Boston Scientific | 2 | $133 |
| Lexicon Pharmaceuticals, Inc. | 3 | $58 |
| Shockwave Medical, Inc | 2 | $56 |
| Regeneron Healthcare Solutions, Inc. | 2 | $51 |
| Bayer | 3 | $51 |
| Sanofi-aventis U.S. LLC | 2 | $44 |
| Alnylam Pharmaceuticals Inc. | 1 | $29 |
| Baxter Healthcare | 1 | $27 |
| Philips North America LLC | 1 | $18 |
How this compares
$786,948 in reported general payments places this provider in the 95th percentile of 727 cardiovascular disease providers in North Carolina.
See all cardiovascular disease providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Morganton
- Sean PokorneyMorganton$1.1M
- John AlexanderDurham$76.8M
- Christopher GrangerDurham$24.7M
- Jonathan PicciniDurham$14.3M
- Adrian HernandezDurham$13.2M
- Gary FelkerDurham$12.7M
- Robert MentzDurham$6M
- Michael ShapiroWinston-Salem$5.4M
- Kirkwood AdamsChapel Hill$4.9M
- Matthew JanikWilmington$4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.